Adial Pharmaceuticals
ADIL----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Adial Pharmaceuticals(ADIL) predict that the EBIT is -2.001 M (+11.72%), Beat estimate;the EPS is -1.48 (+82.59%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B11.72%
-0.00B32.85%
+0.00B44.57%
EPSExceed expectations
-1.4882.59%
-2.7367.88%
+1.250014.71%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf